只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-10 2026-06-22 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 5,000 | US$6.24 | US$31,200.00 | 700,000 | SEC |
| 2026-06-10 2026-06-11 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 6,418 | US$6.21 | US$39,855.78 | 700,000 | SEC |
| 2026-06-09 2026-06-22 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 3,000 | US$6.15 | US$18,450.00 | 700,000 | SEC |
| 2026-06-09 2026-06-11 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 14,500 | US$6.14 | US$89,030.00 | 700,000 | SEC |
| 2026-06-05 2026-06-08 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 15,401 | US$6.40 | US$98,566.40 | 700,000 | SEC |
| 2026-06-04 2026-06-08 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 19,575 | US$6.13 | US$119,994.75 | 700,000 | SEC |
| 2026-05-26 2026-05-27 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 4,000 | US$6.10 | US$24,400.00 | 700,000 | SEC |
| 2026-05-22 2026-05-27 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 3,500 | US$6.08 | US$21,280.00 | 700,000 | SEC |
| 2026-05-21 2026-05-22 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 12,820 | US$6.15 | US$78,843.00 | 700,000 | SEC |
| 2026-05-20 2026-05-22 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 9,400 | US$6.15 | US$57,810.00 | 700,000 | SEC |
| 2026-05-19 2026-05-20 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 9,120 | US$6.37 | US$58,094.40 | 700,000 | SEC |
| 2026-05-18 2026-05-20 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 200 | US$6.62 | US$1,324.00 | 700,000 | SEC |
| 2026-05-15 2026-05-18 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 13,100 | US$6.65 | US$87,115.00 | 700,000 | SEC |
| 2026-05-14 2026-05-18 | GYRE GYRE THERAPEUTICS, INC. | Ye Weiguo Officer · Chief Operating Officer | 卖出（S） | 15,580 | US$6.91 | US$107,657.80 | 700,000 | SEC |
| 2026-05-06 2026-05-07 | GYRE GYRE THERAPEUTICS, INC. | Luo Ying Director,Officer · Chief Executive Officer | 卖出（S） | 10,136 | US$8.04 | US$81,493.44 | 2,565,226 | SEC |
| 2026-05-05 2026-05-07 | GYRE GYRE THERAPEUTICS, INC. | Luo Ying Director,Officer · Chief Executive Officer | 卖出（S） | 179 | US$8.01 | US$1,433.79 | 2,575,362 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| GYRE | 13,028 | 0 | 18,004.4528 | 72.36% | B, Q, N |